LPWM
MRNA icon

Lake Point Wealth Management’s Moderna MRNA Stock Holding History

Lake Point Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-80
Closed -$14K – 481
2022
Q1 		$14K Sell
80
-25
-24% -$4.21K 0.01% 136
2021
Q4 		$27K Buy
+105
New +$30.7K 0.01% 101

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lake Point Wealth Management's MRNA Position: Q2 2022 in Review

Lake Point Wealth Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 80 shares — an estimated $14K sold.

Lake Point Wealth Management first reported a position in MRNA in Q4 2021 and held it in 2 quarters. The position peaked at $27K in Q4 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Lake Point Wealth Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Lake Point Wealth Management sold 80 Moderna shares in Q2 2022, an estimated $14K.
  • Lake Point Wealth Management first reported a position in Moderna in Q4 2021 and held it in 2 quarters.
  • Lake Point Wealth Management's Moderna position peaked at $27K in Q4 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Lake Point Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.